BREAST CANCER STAGE II
Clinical trials for BREAST CANCER STAGE II explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER STAGE II trials appear
Sign up with your email to follow new studies for BREAST CANCER STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer patients as trial tests novel drug combos
Disease control Recruiting nowThis study is testing several combination treatments involving the experimental drug FWD1802 for people with advanced ER-positive/HER2-negative breast cancer that has spread or cannot be removed by surgery. The research aims to find safe doses and see if these combinations can he…
Matched conditions: BREAST CANCER STAGE II
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Radio wave device aims to shrink breast tumors before operation
Disease control Recruiting nowThis study is testing if a new device called TheraBionic P1 can help shrink tumors in people with early-stage breast cancer before they have surgery. The device uses specific radio waves aimed at cancer cells. Researchers will enroll 24 participants to see if adding this device t…
Matched conditions: BREAST CANCER STAGE II
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo attack: radiation & immune drug aim to prime Body's defenses before chemo in breast cancer
Disease control Recruiting nowThis study is testing a new treatment sequence for high-risk breast cancer. It aims to see if giving a short, targeted radiation treatment along with an immune-boosting drug directly into the tumor can better prepare the body's immune system before starting standard chemotherapy.…
Matched conditions: BREAST CANCER STAGE II
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could when you eat boost cancer treatment?
Disease control Recruiting nowThis study is testing whether restricting eating to an 8-hour daily window during cancer treatment improves outcomes and reduces side effects. It will enroll 100 Alaska Native patients with rectal or breast cancer who are receiving standard treatment. Researchers will compare tho…
Matched conditions: BREAST CANCER STAGE II
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Fighting 'Chemo Brain': new study tests drug and exercise combo
Symptom relief Recruiting nowThis study is testing if a drug called memantine, combined with a supervised exercise program, can help reduce memory and thinking problems ('chemo brain') during breast cancer chemotherapy. It will involve 90 women with early-stage breast cancer who are already reporting mild co…
Matched conditions: BREAST CANCER STAGE II
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Cherry juice trial aims to shield cancer patients from Chemo's painful side effect
Symptom relief Recruiting nowThis study is testing whether drinking tart cherry juice can prevent nerve pain (neuropathy) caused by a common chemotherapy drug called paclitaxel. It will enroll 86 people with breast or ovarian cancer who are starting this type of chemo. Participants will be randomly assigned …
Matched conditions: BREAST CANCER STAGE II
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Online program aims to help cancer survivors recover at home
Symptom relief Recruiting nowThis study is testing an 8-week online rehabilitation program designed to help cancer survivors manage long-term side effects and improve their daily function. Researchers will compare the virtual program to usual care for 388 adults who have finished primary cancer treatment but…
Matched conditions: BREAST CANCER STAGE II
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Mar 12, 2026 13:50 UTC
-
New tool aims to empower breast cancer patients in treatment choices
Knowledge-focused Recruiting nowThis study is developing and testing a decision-making tool to help women with early-stage breast cancer choose their treatment options. Researchers will compare how the tool affects communication with doctors and decision-making satisfaction. The study involves 180 participants,…
Matched conditions: BREAST CANCER STAGE II
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
AI vs human: which interpreter makes fewer mistakes in cancer care?
Knowledge-focused Recruiting nowThis study aims to find the best remote language interpreter method for Spanish- and Mandarin-speaking breast cancer patients with limited English skills. Researchers will compare three different interpreting approaches during doctor visits to see which one makes the fewest trans…
Matched conditions: BREAST CANCER STAGE II
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
New web tool aims to cut confusion for young women facing breast cancer surgery
Knowledge-focused Recruiting nowThis study is testing a web-based tool called CONSYDER, designed to help young women (ages 18-44) newly diagnosed with early-stage breast cancer make informed decisions about their surgery. The goal is to see if the tool reduces confusion and anxiety, improves knowledge, and help…
Matched conditions: BREAST CANCER STAGE II
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Researchers seek better way to predict hormone therapy success in breast cancer
Knowledge-focused Recruiting nowThis study aims to understand how the length of hormone-blocking therapy before breast cancer surgery affects treatment outcomes. Researchers will analyze blood and tissue samples from 90 participants with early-stage breast cancer to predict which patients will respond best to t…
Matched conditions: BREAST CANCER STAGE II
Phase: PHASE2 • Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC